The Foreign Corrupt Practices Act units of the Justice Department and the U.S. SEC had sought documents relating to its Chinese operations, the company said in its filing, adding that it is producing records pursuant to these requests. In 2012, the drugmaker had agreed to pay $26.3 million to the top U.S. securities regulator as part of a settlement with the U.S. government following a probe into its use of illegal payments to win business overseas including Russia, Bulgaria, China, and Italy. …read more
Source:: Yahoo Finance
